CDAK - Codiak BioSciences  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CDAK is currently covered by 2 analysts with an average price target of $2.36. This is a potential upside of $2.36 (0%) from yesterday's end of day stock price of $0.

Codiak BioSciences 's activity chart (see below) currently has 8 price targets and 9 ratings on display. The stock rating distribution of CDAK is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 8.5 days.

Highest price target for CDAK is $3, Lowest price target is $1, average price target is $2.36.

Most recent stock forecast was given by ANDREA TAN from GOLDMAN SACHS on 07-Nov-2022. First documented stock forecast 09-Nov-2020.

Best performing analysts who are covering CDAK - Codiak BioSciences :

David Nierengarten Andrea Tan

Currently out of the existing stock ratings of CDAK, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1.4

$1.39 (13900.00%)

2

1 years 5 months 17 days ago

1/3 (33.33%)

$0.6 (75.00%)

1

Buy

7

$6.99 (69900.00%)

24

1 years 9 months 19 days ago

2/6 (33.33%)

$4.12 (143.06%)

16

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CDAK (Codiak BioSciences ) average time for price targets to be met?

On average it took 8.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on CDAK (Codiak BioSciences ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on CDAK (Codiak BioSciences ) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on CDAK (Codiak BioSciences )?

David Nierengarten works at WEDBUSH and has 5 price targets and 3 ratings on CDAK

Which analyst is the currently most bullish on CDAK (Codiak BioSciences )?

David Nierengarten with highest potential upside - $6.99

Which analyst is the currently most reserved on CDAK (Codiak BioSciences )?

Andrea Tan with lowest potential downside - $1.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?